H

HLB Inc
KOSDAQ:028300

Watchlist Manager
HLB Inc
KOSDAQ:028300
Watchlist
Price: 48 100 KRW -0.41% Market Closed
Market Cap: 6.3T KRW

HLB Inc
Accrued Liabilities

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

HLB Inc
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
H
HLB Inc
KOSDAQ:028300
Accrued Liabilities
â‚©5.7B
CAGR 3-Years
-42%
CAGR 5-Years
6%
CAGR 10-Years
18%
Suheung Co Ltd
KRX:008490
Accrued Liabilities
â‚©7.5B
CAGR 3-Years
12%
CAGR 5-Years
9%
CAGR 10-Years
7%
SD Biosensor Inc
KRX:137310
Accrued Liabilities
â‚©11.8B
CAGR 3-Years
29%
CAGR 5-Years
89%
CAGR 10-Years
N/A
B
BioPlus Co Ltd
KOSDAQ:099430
Accrued Liabilities
â‚©1.3B
CAGR 3-Years
53%
CAGR 5-Years
35%
CAGR 10-Years
N/A
T
T&L Co Ltd
KOSDAQ:340570
Accrued Liabilities
â‚©546.5m
CAGR 3-Years
20%
CAGR 5-Years
24%
CAGR 10-Years
N/A
I
Interojo Co Ltd
KOSDAQ:119610
Accrued Liabilities
â‚©4.4B
CAGR 3-Years
7%
CAGR 5-Years
7%
CAGR 10-Years
12%
No Stocks Found

HLB Inc
Glance View

Market Cap
6.3T KRW
Industry
Health Care

Nestled in the bustling corridors of international commerce, HLB Inc. stands as a dynamic player in the healthcare logistics and biomedical sector. Over the years, it has carved a pivotal niche through its adept coordination of high-stakes operations that drive the backbone of medical supply chains. At the heart of its operations are innovative solutions that ensure medical products — ranging from essential pharmaceuticals to state-of-the-art medical devices — navigate smoothly from manufacturers to healthcare providers. This meticulous orchestration not only bolsters the efficiency of healthcare delivery but also makes HLB Inc. an indispensable ally in the realm of modern medicine. The company’s revenue model thrives on the intricate balance of logistical prowess and cutting-edge biomedical services. By leveraging strategic partnerships and technology-driven process improvement, HLB Inc. delivers unparalleled value in both time efficiency and cost-effectiveness. Service contracts with healthcare institutions and governmental bodies serve as significant revenue channels, as the company deftly integrates its logistics network with client demand. Simultaneously, its investments in research and development keep HLB Inc. at the forefront of healthcare innovation, providing an array of bespoke solutions that cater to the evolving landscape of healthcare needs. This dual approach not only solidifies its financial performance but also reflects a commitment to advancing the frontiers of healthcare accessibility and reliability.

Intrinsic Value
1 764.87 KRW
Overvaluation 96%
Intrinsic Value
Price
H

See Also

What is HLB Inc's Accrued Liabilities?
Accrued Liabilities
5.7B KRW

Based on the financial report for Jun 30, 2025, HLB Inc's Accrued Liabilities amounts to 5.7B KRW.

What is HLB Inc's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
18%

Over the last year, the Accrued Liabilities growth was -42%. The average annual Accrued Liabilities growth rates for HLB Inc have been -42% over the past three years , 6% over the past five years , and 18% over the past ten years .

Back to Top